Audentes Therapeutics, Inc. - 05070R104

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q4 2019 · Q3 2019
Value (USD)
Total reported value ($000)
$1.552B
QoQ value delta ($000)
+$1.542B (+14765.34%)
Implied price effect (QoQ)
+113.13%
Shares
Total shares
25,936,829
QoQ shares delta
+25,564,956 (+6874.65%)
Total shares held by funds (by quarter)

Top holders (Q4 2019)

Top 25 only Full list
Early Q2 2021 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 193,020 3,225,613 0.01%
Magnetar Financial LLC 95,421 1,594,605 1.99%
CNH PARTNERS LLC 81,281 1,358,308 1.37%
STATE STREET CORP 78,346 1,309,250 0.01%
FARALLON CAPITAL MANAGEMENT LLC 71,210 1,190,000 3027.64%
TUDOR INVESTMENT CORP ET AL 56,405 942,589 2.53%
RA CAPITAL MANAGEMENT, L.P. 53,999 902,383 1.64%
BANK OF AMERICA CORP /DE/ 50,064 836,641 0.01%
D. E. Shaw & Co., Inc. 49,263 823,251 0.06%
DIMENSIONAL FUND ADVISORS LP 48,281 806,830 0.02%
BAKER BROS. ADVISORS LP 48,154 804,720 0.26%
GOLDMAN SACHS GROUP INC 47,277 790,053 0.01%
UBS Group AG 45,000 752,003 0.02%
GABELLI FUNDS LLC 44,443 742,692 0.29%
GEODE CAPITAL MANAGEMENT, LLC 37,893 633,253 0.01%
WELLINGTON MANAGEMENT GROUP LLP 37,221 622,011 0.01%
MILLENNIUM MANAGEMENT LLC 32,126 536,873 0.04%
NORTHERN TRUST CORP 31,209 521,541 0.01%
Allianz Asset Management GmbH 30,004 501,401 15.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 29,555 493,901 0.94%
JPMORGAN CHASE & CO 25,086 419,221 0.0%
MORGAN STANLEY 20,162 336,931 0.0%
Pentwater Capital Management LP 19,820 331,214 0.32%
MOORE CAPITAL MANAGEMENT, LP 17,952 300,000 0.59%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 16,810 280,904 0.01%